Type
Business expansion
Country
Slovenia
Region
Slovenija; Vzhodna Slovenija; Pomurska
Location of affected unit(s)
Lendava
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.20 - Manufacture of pharmaceutical preparations

200 jobs
Number of planned job creations
Job creation
Announcement Date
21 October 2025
Employment effect (start)
1 January 2026
Foreseen end date
31 December 2026

Description

The pharmaceutical company Lek, which is owned by the Swiss group Sandoz, is currently investing in a project that will create 200 jobs next year.

Construction of a factory in Lendava, where Lek will manufacture active ingredients for similar biological medicines, began in March 2023. The project is progressing according to plan and is expected to be completed next year.

Simon Rečnik, a member of the Sandoz Slovenia management team, says that the plant currently employs 150 people and plans to hire a further 200 in the next year.


Sources

Citation

Eurofound (2025), Lek , Business expansion in Slovenia, factsheet number 203550, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/203550.